SOUTH SAN FRANCISCO, CA, Phase 3 stage biopharmaceutical company focused on the discovery and development of non-absorbed oral drug therapies, has closed an oversubscribed $57.5M Series D. Read More
BOZEMAN, MT, Payment processing solution built specifically for financial advisors to facilitate fee-for-service financial planning billing, closed its seed round of funding today with $500K. Read More
SAN FRANCISCO, CA, Oyster Point Pharmaceuticals announced the completion of a $22 million Series A financing led by New Enterprise Associates and Versant Ventures. Read More